GPT Healthcare last traded at ₹144.01 (2026-10-13). Over the past month the stock moved -10.4%, three months the stock moved +3.5%, year the stock moved -5.9%. Its closing range over 52 weeks is ₹116.02 – ₹165.75, with the latest close 13.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
Business Overview:[1] GPT Healthcare Limited operates as a key regional corporate healthcare provider in Eastern India under the ILS Hospitals brand. The organization has established 5 multi-specialty hospitals with a total capacity of 719 beds, supported by 91 full-time consultants and 630 visiting consultants.
In the latest quarter (Jun 2026), GPT Healthcare reported sales of ₹126.00 crore (+17.8%) and net profit of ₹13.00 crore (+62.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 126.00 | 24.00 | 19.00 | 13.00 | 1.55 |
| Mar 2026 | 126.00 | 23.00 | 18.00 | 15.00 | 1.78 |
| Dec 2025 | 120.00 | 21.00 | 17.00 | 9.00 | 1.14 |
| Sep 2025 | 119.00 | 23.00 | 19.00 | 11.00 | 1.29 |
| Jun 2025 | 107.00 | 17.00 | 16.00 | 8.00 | 0.94 |
| Mar 2025 | 101.00 | 21.00 | 20.00 | 13.00 | 1.57 |
| Dec 2024 | 102.00 | 21.00 | 21.00 | 12.00 | 1.49 |
| Sep 2024 | 106.00 | 23.00 | 22.00 | 15.00 | 1.81 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -1.9% | +5.2% | +2.0% | +9.2% | +12.3% | +17.6% | +24.8% | +17.8% |
| Operating profit growth | -8.0% | +0.0% | -8.7% | -5.6% | +0.0% | +0.0% | +9.5% | +41.2% |
| Net profit growth | +7.1% | +9.1% | +0.0% | -20.0% | -26.7% | -25.0% | +15.4% | +62.5% |
| EPS growth | +7.1% | +3.5% | +0.6% | -22.3% | -28.7% | -23.5% | +13.4% | +64.9% |
| OPM % | 22.0% | 21.0% | 20.0% | 16.0% | 19.0% | 17.0% | 18.0% | 19.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), GPT Healthcare reported sales of ₹473.00 crore (+16.2%) and net profit of ₹42.00 crore (-16.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 473.00 | 84.00 | 18.00 | 42.00 | 5.15 |
| Mar 2025 | 407.00 | 83.00 | 20.00 | 50.00 | 6.08 |
| Mar 2024 | 400.00 | 88.00 | 22.00 | 48.00 | 5.82 |
| Mar 2023 | 361.00 | 74.00 | 21.00 | 39.00 | 4.88 |
| Mar 2022 | 337.00 | 74.00 | 22.00 | 42.00 | 5.21 |
| Mar 2021 | 243.00 | 49.00 | 20.00 | 21.00 | 11.76 |
| Mar 2020 | 212.00 | 36.00 | 17.00 | 11.00 | 6.11 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +14.6% | +38.7% | +7.1% | +10.8% | +1.8% | +16.2% |
| Operating profit growth | +36.1% | +51.0% | +0.0% | +18.9% | -5.7% | +1.2% |
| Net profit growth | +90.9% | +100.0% | -7.1% | +23.1% | +4.2% | -16.0% |
| EPS growth | +92.5% | -55.7% | -6.3% | +19.3% | +4.5% | -15.3% |
| OPM % | 20.0% | 22.0% | 21.0% | 22.0% | 20.0% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for GPT Healthcare.
Get Free AI Stock Analysis FREE →GPT Healthcare Ltd Shows Technical Momentum Shift Amid Market Recovery
GPT Healthcare reports Profit after tax of Rs 106.03 Mln, in the September 2025 quarter
GPT Healthcare shares were last quoted at ₹144.01 (+3.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
GPT Healthcare has a price-to-earnings (P/E) ratio of 27.91 and a price-to-book (P/B) ratio of 8.12. The industry P/E is 101.02.
The 52-week high of GPT Healthcare is ₹175.00 and the 52-week low is ₹114.00.
The market capitalisation of GPT Healthcare is about ₹1,319.03 crore.
In the latest quarter (Jun 2026), GPT Healthcare reported sales of ₹126.00 crore (+17.8%) and net profit of ₹13.00 crore (+62.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, GPT Healthcare has a 3-year ROE of 21.00%, 3-year profit growth of 4.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 65.57% of GPT Healthcare.
GPT Healthcare belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z